Radiotherapy firm Accuray of Sunnyvale, CA, reports that treatments of extracranial tumors using its CyberKnife robotic radiosurgery system increased by 38% worldwide in fiscal year 2008 (end-June 30).
In addition, prostate treatment grew approximately 95% worldwide, while lung, liver, and pancreas treatments experienced double-digit growth.
Accuray estimated that CyberKnife has treated more than 50,000 patients since its inception in 2001, with approximately 34%, or approximately 17,000 individuals worldwide, receiving treatment during fiscal 2008.
Related Reading
Accuray takes Venezuelan order, October 21, 2008
Accuray unveils partnership, new product, September 19, 2008
Accuray partners with Impac, September 16, 2008
Accuray's CFO resigns, September 12, 2008
Accuray takes California order, August 28, 2008
Copyright © 2008 AuntMinnie.com
